sulindac |
Clinoril |
38194-50-2 |
Sulindaco |
Sulindacum |
Aflodac |
Arthrocine |
Sulreuma |
Sulindac sulfoxide |
(Z)-2-(5-Fluoro-2-methyl-1-(4-(methylsulfinyl)benzylidene)-1H-inden-3-yl)acetic acid |
Mobilin |
cis-5-Fluoro-2-methyl-1-((p-methylsulfinyl)benzylidene)indene-3-acetic acid |
CHEBI:9352 |
(Z)-5-Fluoro-2-methyl-1-((p-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid |
cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid |
MK 231 |
MK-231 |
Algocetil |
Artribid |
Citireuma |
Clisundac |
Imbaral |
Reumofil |
Sulinol |
CHEMBL15770 |
Sudac |
2-(1Z)-5-fluoro-1-(4-methanesulfinylphenyl)methylidene-2-methyl-1H-inden-3-ylacetic acid |
2-(3Z)-6-fluoro-2-methyl-3-(4-methylsulfinylphenyl)methylideneinden-1-ylacetic acid |
NCGC00015970-02 |
CAS-38194-50-2 |
DSSTox_CID_3624 |
Sulindacum INN-Latin |
DSSTox_RID_77117 |
DSSTox_GSID_23624 |
Sulindaco INN-Spanish |
C20H17FO3S |
cis-Sulindac |
Sulindac (Clinoril) |
{(1Z)-5-fluoro-2-methyl-1-4-(methylsulfinyl)benzylidene-1H-inden-3-yl}acetic acid |
1H-Indene-3-acetic acid, 5-fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-, (Z)- |
(Z)-2-(5-Fluoro-2-methyl-1-(4-(methylsulfinyl)-benzylidene)-1H-inden-3-yl)acetic acid |
Clinoril (TN) |
CCRIS 3305 |
SR-01000075237 |
32004-68-5 |
EINECS 253-819-2 |
BRN 2951842 |
Moblilin |
(Z)-2-5-Fluoro-2-methyl-1-4-(methylsulfinyl)benzylidene-1H-inden-3-ylacetic Acid |
2-(5-fluoro-2-methyl-1-{4-(methylsulfinyl)phenylmethylene}inden-3-yl)acetic acid |
1H-Indene-3-aceticacid, 5-fluoro-2-methyl-1-4-(methylsulfinyl)phenylmethylene-, (1Z)- |
EINECS 250-893-8 |
EINECS 256-402-3 |
Sulindac USAN:USP:INN:BAN:JAN |
Tocris-1707 |
Prestwick3_000073 |
Spectrum5_001024 |
Lopac-S-8139 |
S 8139 |
Sulindac, >=98.0% |
SCHEMBL4202 |
SCHEMBL4203 |
5-Fluoro-2-methyl-1-((4-(methylsulphinyl)phenyl)methylene)-1H-indene-3-acetic acid |
Lopac0_001070 |
BSPBio_000285 |
BSPBio_002890 |
MLS001056554 |
SPECTRUM1500556 |
Sulindac (JP17/USP/INN) |
BPBio1_000315 |
GTPL5425 |
DTXSID4023624 |
CHEBI:93811 |
HMS501O03 |
cMAP_000021 |
HMS1921C11 |
HMS2092K15 |
HMS2095O07 |
HMS2231N24 |
HMS3259K06 |
HMS3263E22 |
HMS3414N11 |
HMS3649P19 |
HMS3678N09 |
HMS3712O07 |
HMS3884K18 |
Pharmakon1600-01500556 |
HY-B0008 |
Tox21_110270 |
Tox21_301418 |
Tox21_501070 |
BDBM50012899 |
BDBM50103504 |
CCG-39264 |
NSC757344 |
s2007 |
SBB058181 |
AKOS015895412 |
cis-5-Fluoro-2-methyl-1-((p-methylsulfinyl)benzylidenyl)indene-3-acetic acid |
Tox21_110270_1 |
CS-0569 |
DB00605 |
KS-5153 |
LP01070 |
NC00540 |
NSC 757344 |
NSC-757344 |
SDCCGSBI-0051040.P005 |
(Z)-(1)-5-Fluoro-2-methyl-1-((4-(methylsulphinyl)phenyl)methylene)-1H-indene-3-acetic acid |
(Z)-5-Fluoro-2-methyl-1-4-(methyl-sulfinyl)phenylmethylene-1H-indene-3-acetic acid |
1H-Indene-3-acetic acid, 5-fluoro-2-methyl-1-4-(methylsulfinyl)phenylmethylene-, (1Z)- |
IDI1_000601 |
Sulindac 100 microg/mL in Acetonitrile |
NCGC00015970-01 |
NCGC00015970-03 |
NCGC00015970-04 |
NCGC00015970-05 |
NCGC00015970-06 |
NCGC00015970-07 |
NCGC00015970-08 |
NCGC00015970-11 |
NCGC00025268-01 |
NCGC00025268-02 |
NCGC00025268-03 |
NCGC00094349-01 |
NCGC00094349-02 |
NCGC00255143-01 |
NCGC00261755-01 |
NCGC00381714-10 |
BP-30208 |
BS166205 |
LS-14757 |
SMR000326718 |
SBI-0051040.P004 |
Sulindac, meets USP testing specifications |
AB00513800 |
EU-0101070 |
ST51015123 |
SW219748-1 |
U0099 |
9222-EP2275420A1 |
9222-EP2277565A2 |
9222-EP2277566A2 |
9222-EP2277567A1 |
9222-EP2277568A2 |
9222-EP2277569A2 |
9222-EP2277570A2 |
9222-EP2280008A2 |
9222-EP2281815A1 |
9222-EP2284166A1 |
9222-EP2292280A1 |
9222-EP2295055A2 |
9222-EP2295409A1 |
9222-EP2298764A1 |
9222-EP2298765A1 |
9222-EP2301933A1 |
9222-EP2305640A2 |
9222-EP2305652A2 |
9222-EP2308872A1 |
9222-EP2311453A1 |
9222-EP2311827A1 |
9222-EP2314585A1 |
9222-EP2314590A1 |
9222-EP2316829A1 |
C01531 |
D00120 |
AB00052105-07 |
AB00052105_08 |
AB00052105_09 |
Q963093 |
J-008554 |
J-012337 |
SR-01000075237-2 |
SR-01000075237-3 |
SR-01000075237-5 |
SR-01000075237-7 |
BRD-A13946108-001-04-9 |
BRD-A13946108-001-08-0 |
SR-01000075237-13 |
Sulindac, European Pharmacopoeia (EP) Reference Standard |
Sulindac, United States Pharmacopeia (USP) Reference Standard |
(S,Z)-2-(5-Fluoro-2-methyl-1-(4-(methylsulfinyl)benzylidene)-1H-inden-3-yl)acetic acid |
(Z)-5-Fluoro-2-methyl-1-(p-methylsulfinyl)benzylidene-1H-indene-3-acetic Acid |
(Z)-5-fluoro-2-methyl-1-4-(methylsulfinyl)-phenylmethylene-1H-indene-3-acetic acid |
{(1z)-5-fluoro-2-methyl-1-4-(methylsulfinyl)benzylidene-1h-indene-3-yl}acetic acid |
2-(3Z)-6-fluoro-2-methyl-3-(4-methylsulfinylphenyl)methyleneinden-1-ylacetic acid |
Sulindac|(1Z)-5-Fluoro-2-methyl-1-4-(methylsulfinyl)phenylmethylene-1H-indene-3-acetic acid |
|